egfr tki resistance: targeting met amplification
Published 3 years ago • 538 plays • Length 8:00Download video MP4
Download video MP3
Similar videos
-
10:39
egfr tki resistance: progress and challenges
-
2:02
understanding egfr resistance in patients with met-amplified nsclc
-
21:09
mechanisms of resistance to egfr tki and new treatment strategies
-
2:20
osimertinib in advanced non–small-cell lung cancer
-
3:48
mechanisms of resistance to upfront egfr-targeted therapy
-
35:08
cancer survivor story: my successful targeted therapy treatment | ashley's story (2 of 3)
-
28:17
segment 1: egfr tkis in nsclc
-
1:41
osimertinib resistance in non-small cell lung cancer: pathways and potential solutions
-
20:24
targeted treatment with egfr tkis: front line options
-
6:00
case based panel discussions - egfr mutation & met - treatment decisions, level of met amplification
-
8:37
egfr mechanisms of resistance
-
5:32
introduction to egfr inhibitors
-
3:48
azd9291, an egfr-tki, for t790m-mediated resistance in non-small cell lung cancer
-
2:20
new target for treatment resistance after egfr inhibitors found in lung cancer study
-
18:44
2020 ttf egfr breakout piotrowska part 2 - current options upon acquired resistance to osimertinib
-
5:45
egfr tki sequencing
-
20:18
understanding, preventing, and delaying egfr resistance in the era of osimertinib
-
24:36
treatment options for egfr t790m negative acquired resistance
-
6:52
case based panel discussion - egfr mutation with met amplification treatment decisions and the impor
-
1:36
dr. heather wakelee on what to do when resistance to egfr tkis emerges
-
3:34
fish: met 7q31 amplification